43.24
price up icon0.14%   0.06
after-market アフターアワーズ: 43.24
loading
前日終値:
$43.18
開ける:
$42.86
24時間の取引高:
723.02K
Relative Volume:
0.97
時価総額:
$2.51B
収益:
$32.87M
当期純損益:
$674.31M
株価収益率:
3.8063
EPS:
11.36
ネットキャッシュフロー:
$-330.11M
1週間 パフォーマンス:
-0.21%
1か月 パフォーマンス:
+7.72%
6か月 パフォーマンス:
+45.64%
1年 パフォーマンス:
-2.68%
1日の値動き範囲:
Value
$42.26
$43.72
1週間の範囲:
Value
$40.18
$44.25
52週間の値動き範囲:
Value
$23.41
$62.58

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1135)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
488
Name
Twitter
@AgiosPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

AGIO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AGIO
Agios Pharmaceuticals Inc
43.24 2.51B 32.87M 674.31M -330.11M 11.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
03:20 AM

What earnings revisions data tells us about Agios Pharmaceuticals Inc.July 2025 Trends & High Conviction Trade Alerts - newser.com

03:20 AM
pulisher
01:46 AM

Institutional scanner results for Agios Pharmaceuticals Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com

01:46 AM
pulisher
12:52 PM

Is it time to cut losses on Agios Pharmaceuticals Inc.July 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com

12:52 PM
pulisher
12:02 PM

What data driven models say about Agios Pharmaceuticals Inc.’s future - newser.com

12:02 PM
pulisher
11:56 AM

Is Agios Pharmaceuticals Inc. stock supported by strong cash flows2025 Bull vs Bear & Verified Entry Point Detection - newser.com

11:56 AM
pulisher
11:34 AM

Will Agios Pharmaceuticals Inc. benefit from macro trendsQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com

11:34 AM
pulisher
06:38 AM

Can Agios Pharmaceuticals Inc. stock deliver sustainable ROEBuy Signal & Consistent Return Investment Signals - newser.com

06:38 AM
pulisher
05:00 AM

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

05:00 AM
pulisher
04:45 AM

Savvy Advisors Inc. Takes Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat

04:45 AM
pulisher
02:45 AM

Published on: 2025-11-02 02:45:06 - newser.com

02:45 AM
pulisher
02:24 AM

Candlestick signals on Agios Pharmaceuticals Inc. stock todayQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com

02:24 AM
pulisher
01:48 AM

How Agios Pharmaceuticals Inc. (8AP) stock correlates with oil marketsJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com

01:48 AM
pulisher
01:05 AM

Is Agios Pharmaceuticals Inc. (8AP) stock among top earnings playsMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com

01:05 AM
pulisher
Nov 01, 2025

Agios Pharmaceuticals Q3 2025 Earnings Preview - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Agios outlines Q4 2025 PYRUKYND milestones and anticipates U.S. thalassemia approval amid global expansion - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025
pulisher
Nov 01, 2025

RBC Capital Keeps Their Buy Rating on Agios Pharma (AGIO) - The Globe and Mail

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:26:21 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues - sharewise.com

Oct 31, 2025
pulisher
Oct 31, 2025

Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

High Growth Tech Stocks In The US Market With Promising Potential - simplywall.st

Oct 31, 2025
pulisher
Oct 31, 2025

Can Agios Pharmaceuticals Inc. stock surprise with earnings upsideGap Down & Comprehensive Market Scan Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com

Oct 31, 2025
pulisher
Oct 31, 2025

Decoding Agios Pharmaceuticals Inc (AGIO): A Strategic SWOT Insi - GuruFocus

Oct 31, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals: Q3 Earnings Snapshot - CT Insider

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals Inc (AGIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals, Inc. (AGIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 3,302 Shares - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals Inc (AGIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Earnings Call Summary | Agios Pharmaceuticals(AGIO.US) Q3 2025 Earnings Conference - 富途牛牛

Oct 30, 2025
pulisher
Oct 30, 2025

Transcript : Agios Pharmaceuticals, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

[10-Q] AGIOS PHARMACEUTICALS, INC. Quarterly Earnings Report | AGIO SEC FilingForm 10-Q - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

AGIOS PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

Agios Beats Revenue Forecasts And Eyes PYRUKYND’s Future - Finimize

Oct 30, 2025

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):